James L. Riley
Immunology · 2009
A researcher in the Science corpus: 1 paper; trusts 12 researchers and is trusted by 5 researchers here, as inferred from the citation graph.
Subfields
- Immunology — 26 citations into it; #668 of 2,160 by trust here, #1,857 by citations
- Oncology — 17 citations into it; #472 of 1,698 by trust here, #1,404 by citations
Whom James L. Riley trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
- Taku Okazaki
- Arlene H. Sharpe
- G. Freeman
- R. Parry
- B. Fife
- R. Abraham
- E. Wherry
- M. Butte
- Tasuku Honjo
- Kenneth A. Frauwirth
Who trusts James L. Riley overall
- D. Chaplin
- Loise M. Francisco
- Arlene H. Sharpe
- Jaikumar Duraiswamy
- Kristen E. Pauken
- Michael Loran Dustin
- Joel Crespo
Papers from James L. Riley's perspective
Ordered by how strongly the researchers James L. Riley trusts endorse each paper. Same corpus, a different order for every researcher.
- PD-1 immunoreceptor inhibits B cell receptor-mediated signaling by recruiting src homology 2-domain-containing tyrosine phosphatase 2 to phosphotyrosine (Proceedings of the National Academy of Sciences of the United States of America)
- SHP-1 and SHP-2 Associate with Immunoreceptor Tyrosine-Based Switch Motif of Programmed Death 1 upon Primary Human T Cell Stimulation, but Only Receptor Ligation Prevents T Cell Activation1 (Journal of Immunology)
- The PD-1-PD-L pathway in immunological tolerance. (Trends in immunology)
- Programmed death-1 ligand 1 interacts specifically with the B7-1 costimulatory molecule to inhibit T cell responses. (Immunity)
- PD‐1:PD‐L inhibitory pathway affects both CD4+ and CD8+ T cells and is overcome by IL‐2 (European Journal of Immunology)
- The B7 family revisited. (Annual Review of Immunology)
- Restoring function in exhausted CD8 T cells during chronic viral infection (Nature)
- The CD28 signaling pathway regulates glucose metabolism. (Immunity)
- PD-L2 is a second ligand for PD-1 and inhibits T cell activation (Nature Immunology)
- CTLA-4 and PD-1 Receptors Inhibit T-Cell Activation by Distinct Mechanisms (Molecular and Cellular Biology)
Their papers
- PD-1 signaling in primary T cells (2009) — 764 citations